Inhibition of DHCR24 Activates LXRα To Ameliorate Hepatic Steatosis and Inflammation

By using APOE*3-Leiden. CETP mice, researchers reported that SH42 markedly increased desmosterol levels in liver and plasma, reduced hepatic lipid content and the steatosis score, and decreased plasma fatty acid and cholesteryl ester concentrations.